1Fernandes JC,Martel-Pelletier J,Otterness IG,et al. Effects of tenidap on canine experimental osteoarthritis: Ⅱ. Study of the expression of collagenase-1 and IL-1 by in situ hybridization[J].J Rheumatol, 1998, 25(5): 951-958.
2Geis GS. Update on clinical developments with celecoxib, a new specific COX 2 inhibitor:what we can expect[J].J Rheumatol,1999,26(56) :31-36.
3Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of noproxen dose among patients with naproxerr responsive osteoarthritis pain:a randomized,double- blind,placebo, controlled study[J]. Arthritis Rheum, 1999, 42(7): 1370-1377.
4Caldwell JR,Hale ME,Boyd RE,et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double blinded,randomized, multicenter,placebo control
5Likar R,Schafer M,Paulak F,et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis[J]. Anesth Analg,1997, 84(6): 1313-1317.
6Marshall KW. Viscosupplementation for osteoarthritis: current status,uuresolved issues,and future directions[J].J Rheumatol, 1998,25(11): 2056-2057.
7Patel RN,Aitur MG,Dave MN,et al. A novel mechanism of action of chemically modified tetracyclines: inhibitionof COX-2-mediated prostaglandin EZ roduction[J]. J Immunol, 1999,163(6):3459-3467.
8Maheu E,Mazieres B,Valat JP,et al .Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip,a prospective,randomed,double -blinded,placebocontrolled,multicenter clinical trial with a six-month follow u
9Wang JW, Kuo KN. The inRuence of walking mechanics and time on the results of proximal tibia osteotomy [J]. J Bone and Joint Surg, 1990,72: 905.
